What is the radiation risk from diagnostic nuclear medicine?

The radiation risk from diagnostic nuclear medicine is primarily a stochastic risk, meaning a small increase in the probability of cancer induction. At typical diagnostic activity levels, the risk is considered low and far below thresholds for deterministic tissue injury.

Diagnostic nuclear medicine carries a small stochastic cancer risk proportional to effective dose, but this risk is low and typically outweighed by clinical benefit.

The magnitude of risk depends on the effective dose delivered, the patient’s age, sex, and underlying health status. In most cases, the clinical benefit of accurate diagnosis outweighs the increase in cancer risk.

Understanding the physics

In diagnostic nuclear medicine, administered activities are chosen to optimise image quality while minimising radiation exposure. The resulting absorbed doses to organs are generally low and well below levels associated with deterministic effects such as skin injury or marrow suppression.

The principal concern is therefore stochastic risk.

Stochastic effects arise from radiation-induced DNA mutations that may, over time, lead to malignancy. The probability of such effects is thought to increase approximately linearly with dose at low exposure levels, according to the linear no-threshold (LNT) model, which underpins current radiation protection guidelines.

Effective dose is used as a surrogate for stochastic risk because it accounts for organ sensitivity. Typical effective doses for diagnostic nuclear medicine procedures are in the range of a few millisieverts, comparable to or modestly higher than annual background radiation in many regions.

It is important to recognise that effective dose represents a population-based estimate derived from epidemiological data. It does not predict individual cancer development and should not be interpreted as a precise measure of personal risk.

At the dose levels used in diagnostic nuclear medicine, the absolute increase in lifetime cancer risk is small.

We cover specific doses and dose estimates in the Complete Radiology Physics Past Paper Question Bank

Where this matters clinically

Radiation risk must always be considered in the context of clinical benefit. Nuclear medicine studies often provide functional information that cannot be obtained by other modalities.

Understanding the magnitude of risk supports:

  • Justification of imaging procedures

  • Patient counselling

  • Dose optimisation strategies

The goal is not zero dose, but appropriate dose for clinical need.

Related questions

0

Subtotal